Follow
Sumanta Pal
Sumanta Pal
Verified email at coh.org
Title
Cited by
Cited by
Year
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
P Sharma, M Retz, A Siefker-Radtke, A Baron, A Necchi, J Bedke, ...
The lancet oncology 18 (3), 312-322, 2017
18402017
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
DF McDermott, MA Huseni, MB Atkins, RJ Motzer, BI Rini, B Escudier, ...
Nature medicine 24 (6), 749-757, 2018
11382018
Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial
TK Choueiri, B Escudier, T Powles, NM Tannir, PN Mainwaring, BI Rini, ...
The lancet oncology 17 (7), 917-927, 2016
11152016
Bladder cancer, version 3.2020, NCCN clinical practice guidelines in oncology
TW Flaig, PE Spiess, N Agarwal, R Bangs, SA Boorjian, ...
Journal of the National Comprehensive Cancer Network 18 (3), 329-354, 2020
5822020
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
DYC Heng, JC Wells, BI Rini, B Beuselinck, JL Lee, JJ Knox, ...
European urology 66 (4), 704-710, 2014
5262014
Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study
SH Armenian, L Xu, B Ky, C Sun, LT Farol, SK Pal, PS Douglas, S Bhatia, ...
Journal of Clinical Oncology 34 (10), 1122-1130, 2016
5212016
Safety and efficacy of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma: the CheckMate 016 study
HJ Hammers, ER Plimack, JR Infante, BI Rini, DF McDermott, LD Lewis, ...
Journal of Clinical Oncology 35 (34), 3851-3858, 2017
4832017
Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma
TK Choueiri, RJ Motzer, BI Rini, J Haanen, MT Campbell, B Venugopal, ...
Annals of Oncology 31 (8), 1030-1039, 2020
4502020
Triple negative breast cancer: unmet medical needs
SK Pal, BH Childs, M Pegram
Breast cancer research and treatment 125, 627-636, 2011
4302011
Bladder cancer
PE Clark, N Agarwal, MC Biagioli, MA Eisenberger, RE Greenberg, ...
Journal of the National Comprehensive Cancer Network 11 (4), 446-475, 2013
4282013
Avelumab plus axitinib versus sunitinib in advanced renal cell carcinoma: biomarker analysis of the phase 3 JAVELIN Renal 101 trial
RJ Motzer, PB Robbins, T Powles, L Albiges, JB Haanen, J Larkin, XJ Mu, ...
Nature medicine 26 (11), 1733-1741, 2020
4092020
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first …
JJ Ko, W Xie, N Kroeger, J Lee, BI Rini, JJ Knox, GA Bjarnason, S Srinivas, ...
The lancet oncology 16 (3), 293-300, 2015
3952015
Evaluating the older patient with cancer: understanding frailty and the geriatric assessment
SK Pal, V Katheria, A Hurria
CA: a cancer journal for clinicians 60 (2), 120-132, 2010
3382010
Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial
N Dizman, L Meza, P Bergerot, M Alcantara, T Dorff, Y Lyou, P Frankel, ...
Nature medicine 28 (4), 704-712, 2022
3352022
Nivolumab (anti-PD-1; BMS-936558, ONO-4538) in combination with sunitinib or pazopanib in patients (pts) with metastatic renal cell carcinoma (mRCC).
A Amin, ER Plimack, JR Infante, MS Ernstoff, BI Rini, DF McDermott, ...
Journal of Clinical Oncology 32 (15_suppl), 5010-5010, 2014
2942014
S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites
J Deng, Y Liu, H Lee, A Herrmann, W Zhang, C Zhang, S Shen, ...
Cancer cell 21 (5), 642-654, 2012
2862012
Akt inhibitors in clinical development for the treatment of cancer
SK Pal, K Reckamp, H Yu, RA Figlin
Expert opinion on investigational drugs 19 (11), 1355-1366, 2010
2822010
Impact of age, sex, and comorbidity on cancer therapy and disease progression
SK Pal, A Hurria
Journal of clinical oncology 28 (26), 4086-4093, 2010
2742010
Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations
SK Pal, JE Rosenberg, JH Hoffman-Censits, R Berger, DI Quinn, ...
Cancer discovery 8 (7), 812-821, 2018
2682018
Impact of bone and liver metastases on patients with renal cell carcinoma treated with targeted therapy
RR McKay, N Kroeger, W Xie, JL Lee, JJ Knox, GA Bjarnason, ...
European urology 65 (3), 577-584, 2014
2652014
The system can't perform the operation now. Try again later.
Articles 1–20